13F-HR filed by STEMPOINT CAPITAL LP
STEMPOINT CAPITAL LP filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-14, with 62 holding rows worth $378,329,825.
- Accession
- 0001420506-24-000808
- Filer
- CIK 1952142
- Filed
- 2024-05-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 63 entries on the cover page, a total value of $378,329,825 stated on the cover page (in dollars after the unit check, H1), rows summing to $378,329,825 with VALUE read as dollars as filed, 13F file number 028-23724. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ROIVANT SCIENCES LTD | G76279101 | SHS | 3,553,844 | $37,457,516 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 619,789 | $29,012,323 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,100,988 | $26,203,514 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 2,205,899 | $21,860,459 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 627,228 | $20,265,737 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 2,965,721 | $18,921,300 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 1,547,141 | $18,225,321 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 1,003,916 | $17,126,807 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 1,161,060 | $13,770,172 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 2,017,016 | $13,715,709 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 15,067 | $11,721,523 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 233,871 | $10,531,211 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 140,267 | $9,755,570 | dollars as filed | |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 1,848,582 | $9,292,077 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 222,253 | $8,078,897 | dollars as filed | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 1,794,195 | $7,643,271 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 272,448 | $7,391,514 | dollars as filed | |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 274,219 | $6,279,615 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 269,548 | $6,070,221 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 740,877 | $5,623,256 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 491,926 | $5,170,142 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 115,833 | $4,957,652 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 714,773 | $4,824,718 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 121,642 | $4,579,821 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 83,461 | $4,564,482 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 90,647 | $4,553,199 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 605,117 | $4,338,689 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 407,108 | $3,843,100 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 87,393 | $3,834,805 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 129,211 | $3,793,635 | dollars as filed | |
| AVADEL PHARMACEUTICALS PLC | G29687103 | COM SHS | 223,660 | $3,777,617 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 60,129 | $3,743,632 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 1,087,785 | $3,121,943 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 230,273 | $2,676,878 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 62,253 | $2,361,256 | dollars as filed | |
| HELIX ACQUISITION CORP II | G4444H101 | CL A ORD SHS | 200,000 | $2,080,000 | dollars as filed | |
| EFFECTOR THERAPEUTIC EQUCLASS EQUITY | 28202V207 | COMMON STOCK | 132,793 | $1,910,891 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 80,334 | $1,899,899 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 40,723 | $1,787,740 | dollars as filed | |
| ACHILLES THERAPEUTICS PL-ADR | 00449L102 | COM | 1,385,750 | $1,732,188 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 26,893 | $1,641,011 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 43,456 | $1,303,680 | dollars as filed | |
| CARGO THERAPEUTICS INC COM | 14179K101 | Stock | 51,126 | $1,141,132 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 500,000 | $1,075,000 | dollars as filed | put |
| KYVERNA THERAPEUTICS INC | 501976104 | COMMON STOCK | 41,000 | $1,018,440 | dollars as filed | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 1,200,000 | $876,000 | dollars as filed | put |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 168,442 | $675,452 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 825,000 | $515,625 | dollars as filed | put |
| IMMUNOVANT INC | 45258J102 | COM | 250,000 | $318,750 | dollars as filed | call |
| MERUS N V | N5749R100 | COM | 85,000 | $212,500 | dollars as filed | put |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 75,000 | $183,750 | dollars as filed | call |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 175,000 | $157,500 | dollars as filed | put |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 50,000 | $135,000 | dollars as filed | put |
| BIOHAVEN LTD | G1110E107 | COM | 30,000 | $121,500 | dollars as filed | put |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 400,000 | $120,000 | dollars as filed | call |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 40,000 | $75,000 | dollars as filed | put |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 20,000 | $71,000 | dollars as filed | put |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 250,000 | $68,750 | dollars as filed | call |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 750,000 | $56,250 | dollars as filed | put |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 50,000 | $41,250 | dollars as filed | put |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 87,900 | $13,185 | dollars as filed | call |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 10,000 | $10,750 | dollars as filed | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-24-000808 | this filing | 2024-05-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001420506-24-001315 | base | 2024-08-09 | acceptance time not in the bulk data set |